Izrael -
angličtina -
Ministry of Health
odomzo 200 mg
taro international ltd, israel - sonidegib as diphosphate - hard capsule - sonidegib as diphosphate 200 mg - sonidegib - odomzo 200 mg is indicated for the treatment of adult patients with locally advanced basal cell carcinoma which cannot be treated with curative surgery or radiation therapy
Izrael -
angličtina -
Ministry of Health
odomzo 200 mg
taro international ltd, israel - sonidegib as diphosphate - hard capsule - sonidegib as diphosphate 200 mg - sonidegib - odomzo 200 mg is indicated for the treatment of adult patients with locally advanced basal cell carcinoma which cannot be treated with curative surgery or radiation therapy
Izrael -
angličtina -
Ministry of Health
lataro-tim
taro international ltd, israel - latanoprost; timolol as maleate - eye drops, solution - timolol as maleate 5.0 mg/ml; latanoprost 0.05 mg/ml - timolol - reduction of intraocular pressure in patients with open angle glaucoma and ocular hypertension who are insufficiently responsive to topical beta- blockers.
Izrael -
angličtina -
Ministry of Health
ilumya
taro international ltd, israel - tildrakizumab - solution for injection - tildrakizumab 100 mg/ml - tildrakizumab - treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy
Izrael -
angličtina -
Ministry of Health
sildazen
taro international ltd, israel - sildenafil as citrate - suspension for oral spray - sildenafil as citrate 25 mg / 1 ml - sildenafil - sildazen is indicated in the treatment for adult men with erectile dysfunction.
Izrael -
angličtina -
Ministry of Health
tarophen 18 mg
taro international ltd, israel - methylphenidate hydrochloride - tablets extended release - methylphenidate hydrochloride 18 mg - methylphenidate - treatment of attention deficit hyperactivity disorder (adhd)
Izrael -
angličtina -
Ministry of Health
tarophen 27 mg
taro international ltd, israel - methylphenidate hydrochloride - tablets extended release - methylphenidate hydrochloride 27 mg - methylphenidate - treatment of attention deficit hyperactivity disorder (adhd)
Izrael -
angličtina -
Ministry of Health
tarophen 36 mg
taro international ltd, israel - methylphenidate hydrochloride - tablets extended release - methylphenidate hydrochloride 36 mg - methylphenidate - treatment of attention deficit hyperactivity disorder (adhd)
Izrael -
angličtina -
Ministry of Health
tarophen 54 mg
taro international ltd, israel - methylphenidate hydrochloride - tablets extended release - methylphenidate hydrochloride 54 mg - methylphenidate - treatment of attention deficit hyperactivity disorder (adhd)
Izrael -
angličtina -
Ministry of Health
lenalidomide taro 10 mg
taro international ltd, israel - lenalidomide - capsules - lenalidomide 10 mg - lenalidomide - multiple myeloma (mm)lenalidomide is indicated for the treatment of multiple myeloma .myelodysplastic syndromeslenalidomide is indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (mds) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities .lenalidomide 7.5 mg is not indicated for treatment in mds .mantle cell lymphomalenalidomide is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (mcl) .follicular lymphomalenalidomide in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma.